130 related articles for article (PubMed ID: 35067506)
1. Proportionate Cardiovascular Mortality in Chronic Inflammatory Disease in Adults in the United States From 1999 to 2019.
Shah NN; Wass S; Hajjari J; Heisler AC; Malakooti S; Janus SE; Al-Kindi SG
J Clin Rheumatol; 2022 Mar; 28(2):97-103. PubMed ID: 35067506
[TBL] [Abstract][Full Text] [Related]
2. Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999-2018.
Groenendyk JW; Rivera AS; Sinha A; Lloyd-Jones DM; Feinstein MJ
Sci Rep; 2021 Dec; 11(1):23985. PubMed ID: 34907262
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease.
Hammam N; Abdel-Wahab N; Gheita TA
Curr Rheumatol Rev; 2021; 17(1):122-130. PubMed ID: 33030132
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.
Symmons DP; Gabriel SE
Nat Rev Rheumatol; 2011 May; 7(7):399-408. PubMed ID: 21629241
[TBL] [Abstract][Full Text] [Related]
5. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
[TBL] [Abstract][Full Text] [Related]
6. Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities.
Garg S; Bartels CM; Bao G; Helmick CG; Drenkard C; Lim SS
J Rheumatol; 2023 Jan; 50(1):84-92. PubMed ID: 35914786
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus.
Scalzi LV; Hollenbeak CS; Wang L
Arthritis Rheum; 2010 Sep; 62(9):2767-75. PubMed ID: 20506536
[TBL] [Abstract][Full Text] [Related]
8. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
Tsuda S; Sameshima A; Sekine M; Kawaguchi H; Fujita D; Makino S; Morinobu A; Murakawa Y; Matsui K; Sugiyama T; Watanabe M; Suzuki Y; Nagahori M; Murashima A; Atsumi T; Oku K; Mitsuda N; Takei S; Miyamae T; Takahashi N; Nakajima K; Saito S;
Mod Rheumatol; 2020 Sep; 30(5):852-861. PubMed ID: 31483178
[No Abstract] [Full Text] [Related]
9. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
[TBL] [Abstract][Full Text] [Related]
10. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.
Jafri K; Ogdie A; Qasim A; Patterson SL; Gianfrancesco M; Izadi Z; Katz P; Yazdany J; Schmajuk G
Clin Rheumatol; 2018 Feb; 37(2):467-474. PubMed ID: 28993952
[TBL] [Abstract][Full Text] [Related]
11. ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis.
Geraldino-Pardilla L; Gartshteyn Y; Piña P; Cerrone M; Giles JT; Zartoshti A; Bathon JM; Askanase AD
Lupus Sci Med; 2016; 3(1):e000168. PubMed ID: 28079193
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Salmon JE; Roman MJ
Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
[TBL] [Abstract][Full Text] [Related]
13. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
[TBL] [Abstract][Full Text] [Related]
14. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.
Lai CH; Lai WW; Chiou MJ; Lin WC; Yang YJ; Li CY; Tsai LM
Ann Rheum Dis; 2016 Jul; 75(7):1350-6. PubMed ID: 26286017
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory myositis in systemic lupus erythematosus.
Bitencourt N; Solow EB; Wright T; Bermas BL
Lupus; 2020 Jun; 29(7):776-781. PubMed ID: 32281474
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcomes and contraceptive use in patients with systemic lupus Erythematosus, rheumatoid arthritis and women without a chronic illness: a comparative study.
Galappatthy P; Jayasinghe JDD; Paththinige SC; Sheriff RMH; Wijayaratne LS
Int J Rheum Dis; 2017 Jun; 20(6):746-754. PubMed ID: 28205395
[TBL] [Abstract][Full Text] [Related]
18. Impact of Sex on Systemic Lupus Erythematosus-Related Causes of Premature Mortality in the United States.
Falasinnu T; Chaichian Y; Simard JF
J Womens Health (Larchmt); 2017 Nov; 26(11):1214-1221. PubMed ID: 28891746
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.
Al Rayes H; Harvey PJ; Gladman DD; Su J; Sabapathy A; Urowitz MB; Touma Z
Arthritis Res Ther; 2017 Feb; 19(1):31. PubMed ID: 28183339
[TBL] [Abstract][Full Text] [Related]
20. Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition.
Kakuta K; Dohi K; Sato Y; Yamanaka T; Kawamura M; Ogura T; Nakamori S; Fujimoto N; Fujii E; Yamada N; Ito M
J Am Soc Echocardiogr; 2016 Feb; 29(2):173-80. PubMed ID: 26443046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
